Berberine suppresses proinflammatory responses through AMPK activation in macrophages.

Berberine (BBR) has been shown to improve several metabolic disorders, such as obesity, type 2 diabetes, and dyslipidemia, by stimulating AMP-activated protein kinase (AMPK). However, the effects of BBR on proinflammatory responses in macrophages are poorly understood. Here we show that BBR represses proinflammatory responses through AMPK activation in macrophages. In adipose tissue of obese db/db mice, BBR treatment significantly downregulated the expression of proinflammatory genes such as TNF-alpha, IL-1beta, IL-6, monocyte chemoattractant protein-1 (MCP-1), inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX-2). Consistently, BBR inhibited LPS-induced expression of proinflammatory genes including IL-1beta, IL-6, iNOS, MCP-1, COX-2, and matrix metalloprotease-9 in peritoneal macrophages and RAW 264.7 cells. Upon various proinflammatory signals including LPS, free fatty acids, and hydrogen peroxide, BBR suppressed the phosphorylation of MAPKs, such as p38, ERK, and JNK, and the level of reactive oxygen species in macrophages. Moreover, these inhibitory effects of BBR on proinflammatory responses were abolished by AMPK inhibition via either compound C, an AMPK inhibitor, or dominant-negative AMPK, implying that BBR would downregulate proinflammatory responses in macrophages via AMPK stimulation.

[1]  B. Viollet,et al.  Upregulation of Mitochondrial Uncoupling Protein-2 by the AMP-Activated Protein Kinase in Endothelial Cells Attenuates Oxidative Stress in Diabetes , 2008, Diabetes.

[2]  J. A. van der Laak,et al.  Peroxisome Proliferator-activated Receptor γ Activation Promotes Infiltration of Alternatively Activated Macrophages into Adipose Tissue* , 2008, Journal of Biological Chemistry.

[3]  D. James,et al.  Berberine and Its More Biologically Available Derivative, Dihydroberberine, Inhibit Mitochondrial Respiratory Complex I , 2008, Diabetes.

[4]  E. Sakai,et al.  Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-kappaB and Akt pathways. , 2008, European journal of pharmacology.

[5]  L. Franco,et al.  Rosiglitazone Reduces Glucose-Induced Oxidative Stress Mediated by NAD(P)H Oxidase via AMPK-Dependent Mechanism , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[6]  P. Oliveira,et al.  Mitochondrially Targeted Effects of Berberine [Natural Yellow 18, 5,6-dihydro-9,10-dimethoxybenzo(g)-1,3-benzodioxolo(5,6-a) quinolizinium] on K1735-M2 Mouse Melanoma Cells: Comparison with Direct Effects on Isolated Mitochondrial Fractions , 2007, Journal of Pharmacology and Experimental Therapeutics.

[7]  Mark Benson,et al.  Use of herbal preparations in the treatment of oxidant-mediated inflammatory disorders. , 2007, Complementary therapies in medicine.

[8]  T. Ho,et al.  Berberine suppresses inflammatory agents-induced interleukin-1β and tumor necrosis factor-α productions via the inhibition of IκB degradation in human lung cells , 2007 .

[9]  A. Jaeschke,et al.  Metabolic stress signaling mediated by mixed-lineage kinases. , 2007, Molecular cell.

[10]  Cheorl-Ho Kim,et al.  Polygonum cuspidatum, compared with baicalin and berberine, inhibits inducible nitric oxide synthase and cyclooxygenase-2 gene expressions in RAW 264.7 macrophages. , 2007, Vascular pharmacology.

[11]  Hui-yu Liu,et al.  Prolonged Treatment of Primary Hepatocytes with Oleate Induces Insulin Resistance through p38 Mitogen-activated Protein Kinase* , 2007, Journal of Biological Chemistry.

[12]  G. Steinberg.  Inflammation in Obesity is a Common Link Between Defects in Fatty Acid Metabolism and Insulin Resistance , 2007, Cell cycle.

[13]  Marnie L. Gruen,et al.  Diet-Induced Increases in Adiposity, but Not Plasma Lipids, Promote Macrophage Infiltration Into White Adipose Tissue , 2007, Diabetes.

[14]  Xiao Wang,et al.  Berberine stimulates glucose transport through a mechanism distinct from insulin. , 2007, Metabolism: clinical and experimental.

[15]  A. Saltiel,et al.  Obesity induces a phenotypic switch in adipose tissue macrophage polarization. , 2007, The Journal of clinical investigation.

[16]  A. Saltiel,et al.  Increased Inflammatory Properties of Adipose Tissue Macrophages Recruited During Diet-Induced Obesity , 2007, Diabetes.

[17]  S. Yamaoka,et al.  Role of the Toll-like Receptor 4/NF-&kgr;B Pathway in Saturated Fatty Acid–Induced Inflammatory Changes in the Interaction Between Adipocytes and Macrophages , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[18]  Ji-won Park,et al.  Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte , 2006, Experimental & Molecular Medicine.

[19]  G. Hotamisligil,et al.  Inflammation and metabolic disorders , 2006, Nature.

[20]  C. Block,et al.  Mechanisms linking obesity with cardiovascular disease , 2006, Nature.

[21]  M. Gu,et al.  Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK. , 2006, Biochimica et biophysica acta.

[22]  Yuebo Zhang,et al.  Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARγ pathway , 2006 .

[23]  J. McCubrey,et al.  Reactive oxygen species-induced activation of the MAP kinase signaling pathways. , 2006, Antioxidants & redox signaling.

[24]  A. Shirwaikar,et al.  In vitro antioxidant studies on the benzyl tetra isoquinoline alkaloid berberine. , 2006, Biological & pharmaceutical bulletin.

[25]  D. James,et al.  Berberine, a Natural Plant Product, Activates AMP-Activated Protein Kinase With Beneficial Metabolic Effects in Diabetic and Insulin-Resistant States , 2006, Diabetes.

[26]  J. Brusq,et al.  Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine Published, JLR Papers in Press, February 28, 2006. , 2006, Journal of Lipid Research.

[27]  Kunihiro Suzuki,et al.  Metformin Inhibits Cytokine-Induced Nuclear Factor &kgr;B Activation Via AMP-Activated Protein Kinase Activation in Vascular Endothelial Cells , 2006, Hypertension.

[28]  Jacqueline Capeau,et al.  Recent advances in the relationship between obesity, inflammation, and insulin resistance. , 2006, European cytokine network.

[29]  Y. Jang,et al.  Berberine inhibits the production of lysophosphatidylcholine-induced reactive oxygen species and the ERK1/2 pathway in vascular smooth muscle cells. , 2005, Molecules and cells.

[30]  B. Dahiyat,et al.  JNK and Tumor Necrosis Factor-α Mediate Free Fatty Acid-induced Insulin Resistance in 3T3-L1 Adipocytes* , 2005, Journal of Biological Chemistry.

[31]  T. Suganami,et al.  A Paracrine Loop Between Adipocytes and Macrophages Aggravates Inflammatory Changes: Role of Free Fatty Acids and Tumor Necrosis Factor α , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[32]  Jingwen Liu,et al.  Extracellular Signal-Regulated Kinase–Dependent Stabilization of Hepatic Low-Density Lipoprotein Receptor mRNA by Herbal Medicine Berberine , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[33]  G. Hansson.  Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.

[34]  Satoru Inaba,et al.  Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins , 2004, Nature Medicine.

[35]  Jae-Hong Kim,et al.  Lipopolysaccharide Induces Matrix Metalloproteinase-9 Expression via a Mitochondrial Reactive Oxygen Species-p38 Kinase-Activator Protein-1 Pathway in Raw 264.7 Cells1 , 2004, The Journal of Immunology.

[36]  B. Viollet,et al.  5-Aminoimidazole-4-Carboxamide-1-β-4-Ribofuranoside Inhibits Proinflammatory Response in Glial Cells: A Possible Role of AMP-Activated Protein Kinase , 2004, The Journal of Neuroscience.

[37]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[38]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[39]  Henry Jay Forman,et al.  Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. , 2002, American journal of respiratory and critical care medicine.

[40]  A. Garg,et al.  Reactive oxygen intermediates in TNF signaling. , 2002, Molecular immunology.

[41]  S. Deventer,et al.  From Extracellular to Intracellular Targets, Inhibiting MAP Kinases in Treatment of Crohn's Disease , 2002, Annals of the New York Academy of Sciences.

[42]  Joseph L Evans,et al.  Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. , 2002, Endocrine reviews.

[43]  Hsien-Yeh Hsu,et al.  Lipopolysaccharide-mediated Reactive Oxygen Species and Signal Transduction in the Regulation of Interleukin-1 Gene Expression* , 2002, The Journal of Biological Chemistry.

[44]  J. Avruch,et al.  Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. , 2001, Physiological reviews.

[45]  E. Chan,et al.  IFN-γ + LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38 mapk in a mouse macrophage cell line , 2001 .

[46]  Jianping Ye,et al.  Berberine improves glucose metabolism through induction of glycolysis. , 2008, American journal of physiology. Endocrinology and metabolism.

[47]  In-kyu Lee,et al.  AMP-activated protein kinase activation by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) inhibits palmitate-induced endothelial cell apoptosis through reactive oxygen species suppression. , 2008, Journal of pharmacological sciences.

[48]  T. Ho,et al.  Berberine suppresses inflammatory agents-induced interleukin-1beta and tumor necrosis factor-alpha productions via the inhibition of IkappaB degradation in human lung cells. , 2007, Pharmacological research.

[49]  Yuebo Zhang,et al.  Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARgamma pathway. , 2006, Biochemical and biophysical research communications.

[50]  C. Chi,et al.  The anti-inflammatory potential of berberine in vitro and in vivo. , 2004, Cancer letters.

[51]  H. Forman,et al.  Redox signaling and the MAP kinase pathways , 2003, BioFactors.

[52]  J. Hescheler,et al.  Inhibition of Tumor-Induced Angiogenesis and Matrix-Metalloproteinase Expression in Confrontation Cultures of Embryoid Bodies and Tumor Spheroids by Plant Ingredients Used in Traditional Chinese Medicine , 2003, Laboratory Investigation.

[53]  R. Korthuis,et al.  Postischemic anti-inflammatory effects of bradykinin preconditioning. , 2001, American journal of physiology. Heart and circulatory physiology.

[54]  S. Uh,et al.  Evaluation of the role of mitogen-activated protein kinases in the expression of inducible nitric oxide synthase by IFN-gamma and TNF-alpha in mouse macrophages. , 1999, Journal of immunology.

[55]  J. Kyriakis.  Activation of the AP-1 transcription factor by inflammatory cytokines of the TNF family. , 1999, Gene expression.

[56]  M. Wink,et al.  Biochemical activities of berberine, palmatine and sanguinarine mediating chemical defence against microorganisms and herbivores. , 1997, Phytochemistry.

[57]  B. Spiegelman,et al.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.